Exelixis (EXEL) moves to 'Buy' with a de-risked pipeline, strong financials, and breakthrough phase 3 results. See more analysis here.

Learn how to use Excel’s XLOOKUP function to simplify data retrieval, save time, and master spreadsheets with this quick ...